ArticlePloS one2026
Integrated disease model considering mutation-induced infection waves with COVID-19 cases.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19, an unprecedented global pandemic, has caused successive waves that pose unique challenges to public health and epidemiological research. Traditional Susceptible-Infected-Recovered (SIR) models often struggle to capture these complex dynamics, especially given that the virus has spawned multiple sub-variants. To tackle these challenges, we adopt an empirical modeling approach by integrating real-world data from Our World in Data (daily confirmed COVID-19 cases) and GISAID (variant prevalence) into a newly proposed integrated model. Specifically, we sum multiple sigmoidal (logistic) curves, each representing the cumulative infections of a distinct dominant variant, and recalibrate the model whenever a new variant emerges. By incorporating variant-specific parameters, our framework effectively captures the biological and epidemiological characteristics of COVID-19 in a dynamic, data-driven manner. Most importantly, we employ the Pruned Exact Linear Time (PELT) algorithm to provide rigorous mathematical justification for when separate variant models can be legitimately summed: specifically, when variant dominance reaches approximately 50%. This establishes the theoretical foundation that separate logistic models can be additively combined under specific dominance conditions. We evaluate our model using Mean Absolute Percentage Error (MAPE), Root Mean Square Error (RMSE), and Mean Absolute Error (MAE). Our empirical findings confirm that integrating dominant variants is associated with markedly improved accuracy compared to a single-strain approach, based on data from fourteen countries (including South Korea, the United States, and the United Kingdom) and global aggregates. We also provide theoretical motivation for approximating SIR dynamics via logistic functions and discuss how this integrated framework can be refined to enhance predictive performance. In doing so, we demonstrate the feasibility and advantages of iteratively updating epidemiological models in response to emerging variants, thereby offering actionable insights for ongoing and future pandemic management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.